|
|
| Schedule |
|
BIT’s 3rd Annual World Congress of Cancer 2010, Singapore
Theme: We are One Family against Cancers
Time: June 22-25, 2010
Venue: Singapore EXPO, Singapore
|
Program Schedule |
June 21, 2010 (Monday)
Time |
Program |
Place |
08:00-18:00 |
Registration |
Lobby, 1F, EXPO |
June 22, 2010 (Tuesday)
Time |
Program |
Place |
09:00-09:30 |
Opening Ceremony |
Conference Hall, 2F |
09:35-11:15 |
Keynote Forum |
Conference Hall, 2F |
12:00-13:00 |
Luncheon |
Dinning Area, 1F |
13:30-16:40 |
Track 1-1: Breast Cancer, Ovarian and Cervical Cancer (Part I) |
Conference Hall A, 2F |
13:30-15:10 |
Track 1-2: Prostate Cancer |
Conference Hall E, 2F |
13:30-17:05 |
Track 1-4: Nuclear Oncology-Diagnosis and Therapy |
Conference Hall B, 2F |
13:10-17:25 |
Track 2-1: Cancer Epidemiology, Biostatistics and Prevention |
Conference Hall C, 2F |
13:30-16:45 |
Track 2-2: Molecular and Cell Oncology (Part I) |
Conference Hall D, 2F |
15:25-17:05 |
Track 2-2: Molecular and Cell Oncology (Part II) |
Conference Hall E, 2F |
13:30-15:45 |
Track 3-1: Stem Cell in Cancers |
Conference Hall F, 2F |
15:45-16:25 |
Track 3-2: RNA Technologies in Cancer Research |
Conference Hall F, 2F |
13:30-14:20 |
Track 4-1: Functional Genomics in Cancer Drug Discovery and Development |
Conference Hall G, 1F |
14:20-16:15 |
Track 4-2: Anticancer Drug Resistance and New Molecule Searching |
Conference Hall G, 1F |
13:30-16:05 |
Track 5-1: Cancer Biomarkers, Molecular Diagnostics, Blood Tests, and Biopsy |
Conference Hall H, 1F |
16:05-17:05 |
Track 5-2: Cancer Pathology and Imaging: From Biochemical Analysis to
Diagnostic Tool |
Conference Hall H, 1F |
18:30-20:30 |
Welcome Banquet |
Bliss Garden Restaurant, 2F |
June 23, 2010 (Wednesday)
Time |
Program |
Place |
08:30-10:10 |
Track 1-5: Breast Cancer, Ovarian and Cervical Cancer (Part II) |
Conference Hall A, 2F |
10:25-12:05 |
Track 1-6: Pediatric Oncology |
Conference Hall A, 2F |
08:30-11:05 |
Track 2-3: Cancer Genomics, Genetics, Epigenetics and System Biology |
Conference Hall B, 2F |
11:05-11:45 |
Track 2-4: Hematology-Oncology |
Conference Hall B, 2F |
11:25-12:05 |
Track 3-3: Gene, Tissue Chips, Lab-On-Chip and Microfluidics |
Conference Hall C, 2F |
10:45-11:25 |
Track 4-3: Neuro-oncological Cancer Drug Discovery |
Conference Hall C, 2F |
08:30-09:10 |
Track 5-3: Cancer Genetic Screening and Prognosis |
Conference Hall C, 2F |
09:10-10:45 |
Track 5-4: Nuclear Medicine and Diagnosis |
Conference Hall C, 2F |
08:30-09:50 |
Track 6-1: Clinical Lung Cancer, Diagnostics and Treatment |
Conference Hall F, 2F |
09:50-11:45 |
Track 6-2: Molecular Epidemiology, Pathology and Prevention |
Conference Hall F, 2F |
10:45-12:05 |
Track 6-3: Molecular Profiling of Lung Cancer |
Conference Hall D, 2F |
08:30-09:30 |
Track 7-1: Acute Symptom Care Oncology Nursing & Quality Care |
Conference Hall G, 1F |
June 23, 2010 (Wednesday)
Time |
Program |
Place |
08:30-10:45 |
Track 7-2: Palliative Care, Psycho -Oncology, Nutritional Protection, Pain
Management |
Conference Hall D, 2F |
09:30-10:30 |
Track 8-1: Advances In Cancer Screening and Monitoring |
Conference Hall G, 1F |
08:30-10:45 |
Track 8-2: Botanical Medicine for Cancers in Clinical Practice |
Conference Hall E, 2F |
10:45-11:50 |
Track 8-3: Nutritional Oncology and Food -borne Carcinogens |
Conference Hall E, 2F |
12:00-13:00 |
Luncheon |
Dinning Area, 1F |
13:30-16:45 |
Track 1-3: Colorectal and Colon Cancers |
Conference Hall A, 2F |
13:30-14:10 |
Track 1-7: Practical Chemotherapy and Anticancer Drug -Drug Interactions |
Conference Hall B, 2F |
14:10-15:10 |
Track 1-8: Oesophageal and Gastrointestinal Cancers |
Conference Hall B, 2F |
15:25-17:05 |
Track 1-9: Clinical Oncology |
Conference Hall B, 2F |
13:30-15:10 |
Track 1-10: Tumor Pathology |
Conference Hall H, 1F |
13:30-14:10 |
Track 2-5: Tumor Virology |
Conference Hall C, 2F |
13:30-16:05 |
Track 3-4: Proteomics in Cancer Research |
Conference Hall D, 2F |
14:10-15:30 |
Track 3-5: PET in Oncology |
Conference Hall C, 2F |
13:30-15:10 |
Track 4-4: New Cancer Biomarkers as Drug Targets |
Conference Hall E, 2F |
15:30-16:20 |
Track 4-5: Anticancer Drugs Targeting Protein Kinase Inhibitors |
Conference Hall C, 2F |
13:30-17:05 |
Track 4-6: Anticancer Drugs Targeting Signalling Pathways and Regulators |
Conference Hall F, 2F |
15:25-17:05 |
Track 4-7: Inhibition of Metastasis to Vascular Targeting and
Anti-Angiogenesis |
Conference Hall E, 2F |
13:30-14:10 |
Track 5-5: Immunohistochemical Diagnosis of Cancer |
Conference Hall G, 1F |
14:10-15:10 |
Track 5-6: DNA Level in Blood and Stool in Cancer Diagnosis |
Conference Hall G, 1F |
15:25-15:45 |
Track 7-3: Cancer Epidemiology, Public Healthcare, and Reimbursement
Policy |
Conference Hall G, 1F |
15:45-17:05 |
Track 8-4: Cancer Rehabilitation, Nutrition and Complementary Therapy |
Conference Hall G, 1F |
June 24, 2010 (Thursday)
Time |
Program |
Place |
10:50-12:05 |
Track 1-11: Practical Gynecologic Oncology |
Conference Hall A, 2F |
08:30-10:50 |
Track 1-12: Head, Nasopharyngeal, Neck, Thyroid and Brain Cancers |
Conference Hall A, 2F |
08:30-09:50 |
Track 1-13: Rectum, Liver, Cholecyst and Pancreatic Cancer |
Conference Hall B, 2F |
08:30-09:10 |
Track 1-14: Lymphoma and Melanoma |
Conference Hall C, 2F |
09:10-11:25 |
Track 2-6: Tumor Immunology and Immunotherapy |
Conference Hall C, 2F |
08:30-12:05 |
Track 2-7: Cancer/Tumor Adhesion, Migration, Invasion, and Metastasis |
Conference Hall D, 2F |
09:20-10:10 |
Track 3-6: Cancer Digital Imaging Technologies |
Conference Hall E, 2F |
09:50-11:50 |
Track 4-8: Apoptotic Inducers, Targeting Apoptosis Signaling Pathways and
their Mediators |
Conference Hall B, 2F |
08:30-09:20 |
Track 4-9: Anticancer Drug Discovery Targeting Telomerase |
Conference Hall E, 2F |
10:25-11:45 |
Track 4-10: New Anticancer Drug Discovery Targeting Cell Life Cycle |
Conference Hall E, 2F |
11:45-12:05 |
Track 4-11: Photodynamic Cancer Therapeutic Development |
Conference Hall E, 2F |
10:25-11:05 |
Track 4-12: Anticancer Gene Therapy |
Conference Hall F, 2F |
June 24, 2010 (Thursday)
Time |
Program |
Place |
08:30-10:10 |
Track 4-21: Multi-modal Attacks on Cancer: Focal Therapies as Immune
Promoters |
Conference Hall F, 2F |
11:05-12:05 |
Track 5-7: Robotics and Tumor Mini -invasive Therapy |
Conference Hall F, 2F |
08:30-11:25 |
Track 5-8: Radiotherapy and Medical Device Therapy for Cancer |
Conference Hall G, 1F |
08:30-09:50 |
Track 6-4: NSCLC & SCLC and Interventions |
Conference Hall H, 1F |
09:50-11:45 |
Track 6-5: Chemotherapy for Lung Cancer |
Conference Hall H, 1F |
12:00-13:00 |
Luncheon |
Dinning Area, 1F |
13:30-14:30 |
Track 1-15: Skin Cancer and Sarcomas |
Conference Hall A, 2F |
13:30-15:10 |
Track 1-16: Leukemia and Myelodysplasia |
Conference Hall B, 2F |
14:30-16:05 |
Track 1-17: Chest, Bone, and Soft Tissue Cancers |
Conference Hall A, 2F |
16:05-16:45 |
Track 1-18: Clinical Progress in Urology, Kidney/Renal Cancers |
Conference Hall B, 2F |
13:30-15:10 |
Track 2-8: Tumor Microenvironmen t and Therapy |
Conference Hall C, 2F |
15:25-16:45 |
Track 2-9: Chromatin Regulation and Cancers |
Conference Hall C, 2F |
15:25-16:05 |
Track 3-7: Laparoscopic Techniques in Uro -Oncology and Digestive System
Cancer |
Conference Hall B, 2F |
13:30-15:10 |
Track 4-13: Stem Cells and Cancer Cell Therapy |
Conference Hall D, 2F |
15:25-16:40 |
Track 4-14: RNAi, siRNA and mRNA Based Anticancer Drug Discovery |
Conference Hall D, 2F |
13:30-14:10 |
Track 4-15: Therapeutic Antibodies |
Conference Hall E, 2F |
14:10-15:10 |
Track 4-16: Therapeutic Cancer Vaccines |
Conference Hall E, 2F |
15:25-16:45 |
Track 4-17: Medicinal Chemistry in Anticancer Drug Discovery |
Conference Hall E, 2F |
13:30-15:30 |
Track 5-9: Cancer Surgery, Interventional Therapy and Symptom Management |
Conference Hall F, 2F |
15:30-16:10 |
Track 5-10: Clinical Update on Combination Cancer Therapy |
Conference Hall F, 2F |
16:10-17:10 |
Track 6-6: Translational Research and Clinical Trials |
Conference Hall F, 2F |
June 25, 2010 (Friday)
Time |
Program |
Place |
10:25-11:15 |
Track 2-10: Bioinformatics and Med-informatics in Cancer Research |
Conference Hall G, 1F |
08:30-09:50 |
Track 2-11: Mechanisms of Resistance in Cancer Cells |
Conference Hall G, 1F |
09:10-10:45 |
Track 2-12: Cancer Metastases Research |
Conference Hall H, 1F |
08:30-09:10 |
Track 2-13: Surgical Oncology |
Conference Hall H, 1F |
10:45-11:35 |
Track 4-18: Pharmacology, ADMET and Anticancer Drug Discovery |
Conference Hall H, 1F |
08:30-10:10 |
Track 4-19: Nanotechnology and Novel Drug Delivery Systems |
Conference Hall J, 1F |
11:15-11:40 |
Track 4-20: Innovative Designs of Phase I/II Trials, Regulatory Issues and
Translational Research |
Conference Hall G, 1F |
12:00-13:00 |
Luncheon |
Dinning Area, 1F |
|
|
|